OrthoPediatrics Corp.

AI Score

0

Unlock

23.64
-1.36 (-5.44%)
At close: Jan 14, 2025, 3:59 PM

OrthoPediatrics Corp. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Dec 31, 2020Dec 31, 2019Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017
Spine Revenue 15.63M 10.20M 9.66M 10.30M 10.89M 7.07M 8.04M 9.98M 9.42M 5.98M 7.17M 7.27M 7.66M 6.64M 4.89M 4.90M 2.69M 8.29M 3.30M
Spine Revenue Growth +53.24% +5.58% -6.21% -5.41% +54.03% -12.09% -19.38% +5.92% +57.46% -16.58% -1.29% -5.11% +15.39% +35.68% -0.12% +82.38% -67.60% +151.17% n/a
Sports Medicine And Other Revenue 1.30M 1.18M n/a 862.00K 1.15M 1.12M n/a 1.08M 939.00K 918.00K n/a 996.00K 1.10M n/a n/a n/a n/a n/a n/a
Sports Medicine And Other Revenue Growth +9.83% n/a n/a -25.17% +2.77% n/a n/a +14.91% +2.29% n/a n/a -9.86% n/a n/a n/a n/a n/a n/a n/a
Trauma And Deformity Revenue 37.64M 33.30M n/a 28.81M 27.51M 23.39M n/a 23.89M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Trauma And Deformity Revenue Growth +13.03% n/a n/a +4.70% +17.61% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Non-Us Revenue 37.72M 29.87M 20.27M 8.11M 17.50M 14.10M 34.91M
Non-Us Revenue Growth +26.29% +47.38% +149.85% -53.64% +24.11% -59.61% n/a
United States Revenue 111.01M 92.42M 77.78M 62.97M 55.05M 43.46M n/a
United States Revenue Growth +20.12% +18.82% +23.53% +14.37% +26.68% n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Mar 31, 2015
Selling, General, and Administrative Revenue 43.05M 39.14M 33.87M 26.55M 32.09M 32.82M 29.88M 27.50M 27.04M 26.98M 22.93M 22.03M 20.90M 21.96M 20.99M 19.47M 19.06M 16.20M 15.45M 15.58M 16.04M 14.18M 12.16M 11.10M 12.03M 12.28M 12.10M 12.10M 9.12M 8.72M 7.57M 9.03M 7.18M 7.10M 6.96M 5.78M
Selling, General, and Administrative Revenue Growth +9.98% +15.56% +27.56% -17.25% -2.22% +9.83% +8.67% +1.72% +0.21% +17.68% +4.04% +5.45% -4.86% +4.64% +7.81% +2.15% +17.68% +4.87% -0.84% -2.88% +13.14% +16.58% +9.51% -7.68% -2.02% +1.48% +0.01% +32.62% +4.58% +15.28% -16.21% +25.76% +1.08% +2.00% +20.49% n/a
Research and Development Revenue 2.58M 2.54M 3.00M 2.75M 2.39M 2.79M 2.27M 2.03M 2.21M 1.75M 2.03M 1.61M 1.30M 1.32M 1.31M 2.05M 1.08M 881.00K 1.26M 1.91M 1.40M 1.23M 1.21M 1.28M 1.12M 1.11M 1.22M 941.00K 1.13M 668.00K 687.00K 624.00K 501.00K 589.00K 507.00K 479.00K
Research and Development Revenue Growth +1.34% -15.18% +9.14% +15.08% -14.51% +23.00% +11.60% -7.80% +26.27% -13.81% +26.06% +23.50% -1.74% +1.30% -36.20% +90.34% +22.25% -30.36% -33.60% +36.46% +13.13% +1.73% -5.01% +13.81% +0.63% -8.46% +29.44% -16.50% +68.71% -2.77% +10.10% +24.55% -14.94% +16.17% +5.85% n/a
Sales and Marketing Revenue 16.75M 16.59M 14.17M 12.44M 13.58M 13.16M 12.22M 10.95M 11.92M 12.43M 9.76M 9.99M 9.86M 10.88M 8.95M 9.43M 9.24M 5.62M 7.56M 8.36M 8.77M 7.61M 6.55M 6.56M 7.15M 6.78M 6.08M 5.41M 5.63M 5.30M 4.19M 4.26M 4.29M 4.34M 3.77M 3.21M
Sales and Marketing Revenue Growth +0.95% +17.11% +13.91% -8.42% +3.17% +7.77% +11.61% -8.17% -4.12% +27.39% -2.28% +1.26% -9.32% +21.53% -5.13% +2.12% +64.36% -25.70% -9.52% -4.69% +15.32% +16.18% -0.17% -8.28% +5.52% +11.47% +12.47% -4.05% +6.30% +26.41% -1.60% -0.68% -1.08% +15.01% +17.56% n/a